title: On-treatment biomarkers in metastatic renal cell carcinoma: towards individualization of prognosis?
authors.affiliation: a Department of Oncology , Aarhus University Hospital , Aarhus , Denmark.
authors.forename: Frede
authors.initials: F
authors.lastname: Donskov
authors.affiliation: b Department of Medical Oncology, Tom Baker Cancer Centre , University of Calgary , Calgary , AB , Canada.
authors.forename: Daniel Y C
authors.initials: DY
authors.lastname: Heng
authors.affiliation: c Cleveland Clinic , Taussig Cancer Institute , Cleveland , OH , USA.
authors.forename: Brian I
authors.initials: BI
authors.lastname: Rini
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis*; D002292:Carcinoma, Renal Cell / Q000473:pathology* / Q000628:therapy; D006801:Humans; D007680:Kidney Neoplasms / Q000473:pathology* / Q000628:therapy; D009362:Neoplasm Metastasis; D057285:Precision Medicine / Q000379:methods; D011379:Prognosis
chemical_list: D014408:Biomarkers, Tumor
keywords: IMDC; Prognostic biomarkers; VEGF-Targeted therapy; metastatic renal cell carcinoma; toxicity